CIK 0001382574 · Non-accelerated filer<br>Smaller reporting company
Scienture Holdings, Inc.
Sign in to watch- Ticker
- SCNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (800) 261 0281
- Business address
- 20 AUSTIN BLVD., COMMACK, NY, 11725
- Former names
- TRxADE HEALTH, INC, TRXADE GROUP, INC., XCELLINK INTERNATIONAL INC., Bluebird Exploration Co.
- 4 Open-market buy Director bought 1,500 shares at $1.08 ($1,620)
- 4/A Open-market buy CEO bought 10,000 shares at $1.30 ($13,000)
- 4 Open-market buy CEO bought 10,000 shares at $13,000.00 ($130,000,000)
- 4 Open-market buy Director bought 2,000 shares at $1.26 ($2,520)
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Open-market sale Former Director sold 900 shares at $4.45 ($4,005)
- 4 Grant or award Director acquired 10,912 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 10,912 shares (grant or award)
- 4 Returned to the company Former Director returned 8,041 shares (to the company)
- 4 Returned to the company Former Director returned 8,041 shares (to the company)
- 3 Insider Initial Statement of Ownership
- 4 Gift Director gave 2,550 shares (gift)
- 4 Open-market sale President sold 7,500 shares at $4.39 ($32,909)
- 4 Grant or award Director acquired 10,721 shares (grant or award)
- 4 Open-market sale Director sold 900 shares at $4.68 ($4,212)
- 4 Grant or award Director acquired 10,721 shares (grant or award)
- 4/A Open-market sale Director sold 500 shares at $5.30 ($2,650)
- 4/A Grant or award Director acquired 8,987 shares (grant or award)
Page 2 of 4 · 75 filings